Showing results (121-130 of 510) with videos related to
Sort By:
Pageof 51
Neurotoxicity Research|June 22, 2006
Neuroprotective and neurorestorative strategies for neuronal injuryM F Beal, T Palomo, R M Kostrzewa, et al.Brain Research|March 30, 1999
Increased nitrotyrosine immunoreactivity in substantia nigra neurons in MPTP treated baboons is blocked by inhibition of neuronal nitric oxide synthaseR J Ferrante, P Hantraye, E Brouillet, et al.Neuroreport|November 17, 2001
Lipoic acid improves survival in transgenic mouse models of Huntington's diseaseO A Andreassen, R J Ferrante, A Dedeoglu, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 1, 1990
Cerebral synthesis and release of kynurenic acid: an endogenous antagonist of excitatory amino acid receptorsK J Swartz, M J During, A Freese, et al.Neuroreport|November 4, 1996
NGF attenuates 3-nitrotyrosine formation in a 3-NP model of Huntington's diseaseW R Galpern, R T Matthews, M F Beal, et al.Experimental Neurology|March 1, 1997
MPP+ produces progressive neuronal degeneration which is mediated by oxidative stressJ Fallon, R T Matthews, B T Hyman, et al.Neuroscience Letters|August 15, 1994
Aminooxyacetic acid striatal lesions attenuated by 1,3-butanediol and coenzyme Q10E Brouillet, D R Henshaw, J B Schulz, et al.Brain Research|May 2, 1998
Coenzyme Q10 attenuates the 1-methyl-4-phenyl-1,2,3,tetrahydropyridine (MPTP) induced loss of striatal dopamine and dopaminergic axons in aged miceM F Beal, R T Matthews, A Tieleman, et al.Journal of Molecular Neuroscience : MN|October 23, 2001
Therapeutic efficacy of EGb761 (Gingko biloba extract) in a transgenic mouse model of amyotrophic lateral sclerosisR J Ferrante, A M Klein, A Dedeoglu, et al.The American Journal of Psychiatry|December 1, 1995
Tardive dyskinesia and substrates of energy metabolism in CSFD C Goff, G Tsai, M F Beal, et al.Pageof 51